Axis 4: Integrating Systems in Neuroscience
Leaders: Laurent Fagni and Christian Hamel
One of the most important challenge of this XXIst century will be the discovery of efficient therapies against neurological disorders. To this end, a reasonable strategy is to improve our understanding of sensory organs and brain functions and dysfunctions. We follow this strategy and focus on neurodegenerative diseases of genetic and epigenetic origin, with the objective to unravel the molecular and cellular substrates that are responsible for neuronal cell death. We use a multi-scale approach with genetic and cellular analyses, in animals and human. We will generate new transgenic animal models and bioactive molecules. Thus we believe that our work will contribute to the discovery of novel, customized and more efficient therapeutic treatments.
MYELIN Avenir Team
INM - U 1051
80, rue Augustin Fliche, 34091 Montpellier
Phone: + 33 4 99 63 61 40
Email : email@example.com